SCHEMBL27780880

SCHEMBL27780880

NC(=S)NC1CCN(CCc2ccccc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.67
▸ DRD4 P21917 2/20 0.56
▸ ACHE P22303 1/20 0.55
▸ CXCR3 P49682 1/20 0.54
▸ CCR3 P51677 1/20 0.54
▸ KCNH2 Q12809 1/20 0.52
▸ HTR2A P28223 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ HTR2C P28335 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SLC6A3 Q01959 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3325622 0.85 ALDH1A1 (0.68) SIGMAR1DRD4ACHEKCNH2ALDH1A1
Bromide SCHEMBL8824061 0.84 ALDH1A1 (0.67) SIGMAR1DRD4ACHEKCNH2ALDH1A1
SCHEMBL5844682 0.83 BACE1 (0.61) SIGMAR1DRD4ACHEKCNH2ALDH1A1
SCHEMBL27430491 0.82 SIGMAR1 (0.79) SIGMAR1DRD4ACHECXCR3CCR3
SCHEMBL11667042 0.80 ACHE (0.63) SIGMAR1ACHECCR3KCNH2HTR2A
SCHEMBL8023030 0.80 SIGMAR1 (0.75) SIGMAR1DRD4ACHECXCR3KCNH2
SCHEMBL11470062 0.80 ALDH1A1 (0.60) SIGMAR1CXCR3ALDH1A1MAPK1KMT2A
Hydrochloric Acid SCHEMBL28785171 0.79 ACHE (0.61) SIGMAR1ACHECCR3KCNH2HTR2A
SCHEMBL17512174 0.79 DRD4 (0.76) SIGMAR1DRD4KCNH2HTR2ACYP1A2
SCHEMBL5504017 0.79 SIGMAR1 (0.82) SIGMAR1DRD4ACHECXCR3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101663299-A Thia (dia) zoles as fast dissociating dopamine 2 receptor antagonists JANSSEN PHARMACEUTICA NV 2010-03-03 — — CN disclosed
Send feedback